MYC and neoplasm: While the inhibition of complex-I activity may play a role in the anti-tumor effects of IACS-010759 treatment, our findings demonstrate that the downregulation of MYC is a significant event that is important for determining the cell-fate of G3 MB cells in response to IACS-010759 treatment.